Effect of Nebulized Milrinone on Right Ventricular Hemodynamics in Adult Cardiac Surgery

Sponsor
Ain Shams University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05132153
Collaborator
(none)
70
1
2
11.1
6.3

Study Details

Study Description

Brief Summary

The primary aim of this study was to investigate the effect inhaled milrinone given before CPB on improving the right ventricular function measured by transesophageal echocardiography (TEE) at time of CPB separation.

Condition or Disease Intervention/Treatment Phase
Phase 4

Detailed Description

The investigator will include (70) patients planned for elective adult cardiac surgery (Coronary revascularization surgery, Mitral valve surgery, Aortic valve surgery or complex surgery (either two or more valves or valves and coronary revascularization surgery). All surgery should be with CPB. All patients will be diagnosed with preoperative PH. After separation of CPB the patients evaluated as regard the hemodynamics (MAP, HR), the inotropic score as additional intravenous milrinone in the case of low cardiac output or presence of post-CPB PH or RV failure with reduced contractility documented using TEE. Left ventricular EF, and right ventricular hemodynamics represented by RV function measured by (tricuspid annulus plane systolic excursion (TAPSE), fractional area change FAC), and right ventricular systolic pressure by doppler (RVSP) which represent the pulmonary artery pressure all data will be assessed by transesophageal ECHO after anesthesia, immediately before CPB and immediately after separation from CPB all these data will be recorded in the study.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
70 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effect of Nebulized Milrinone on Right Ventricular Hemodynamics in Adult Cardiac Surgery
Actual Study Start Date :
Oct 17, 2021
Anticipated Primary Completion Date :
Sep 1, 2022
Anticipated Study Completion Date :
Sep 20, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: (Group A) will receive milrinone

Patients will receive milrinone 50 microgram/kg in 5ml volume, over 5 min by nebulization

Drug: Milrinone
will be given by nebulization

Placebo Comparator: (Group B) will receive normal saline

Patients will receive 5 ml saline by nebulization over 5 min

Drug: Normal saline
will be given by nebuliztion

Outcome Measures

Primary Outcome Measures

  1. Effect of inhaled milrinone on improvement of right ventricular function [After 15 minutes of inhaled milrinone intraoperative and repeated after 12, 24 hours in intensive care unit]

    The right ventricle function will be assessed by Fractional area change ( Change in area between systole and diastole by echocardiograph ( intraoperative and postoperative)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Eligibility criteria:
  • elective adult cardiac surgery (Coronary revascularization surgery, Mitral valve surgery, Aortic valve surgery or complex surgery (either two or more valves or valves and coronary revascularization surgery).

  • All surgery should be with CPB.

  • All patients will be diagnosed with preoperative PH. PH was defined as a mean pulmonary artery pressure (MPAP) 30 mmHg or a systolic pulmonary artery pressure (SPAP) 40 mmHg, measured during preoperative right-sided catheterization or estimated by using doppler transthoracic echocardiography.

Exclusion Criteria:
  • Cardiac surgery without CPB.

  • Hemodynamic instability in the preoperative time (defined as acute requirement for vasoactive support or mechanical device).

  • Adult congenital heart disease planned for corrective surgery.

  • Contraindication to transesophageal echocardiography (TEE).

  • Any surgery involves tricuspid valve annulus as it will compromise the accuracy of RV function assessment by TEE.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Samar Soliman Cairo Nasr City Egypt 11511

Sponsors and Collaborators

  • Ain Shams University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
samar mohammed, Lecturer of Anesthesia, Ain Shams University
ClinicalTrials.gov Identifier:
NCT05132153
Other Study ID Numbers:
  • FAMSU R 174/2021
First Posted:
Nov 24, 2021
Last Update Posted:
Jul 20, 2022
Last Verified:
Jul 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 20, 2022